Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease
- PMID: 22152305
- PMCID: PMC3658280
- DOI: 10.1016/j.cmet.2011.11.004
Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease
Abstract
Approximately one-third of the U.S. population has nonalcoholic fatty liver disease (NAFLD), a condition closely associated with insulin resistance and increased risk of liver injury. Dysregulated mitochondrial metabolism is central in these disorders, but the manner and degree of dysregulation are disputed. This study tested whether humans with NAFLD have abnormal in vivo hepatic mitochondrial metabolism. Subjects with low (3.0%) and high (17%) intrahepatic triglyceride (IHTG) were studied using (2)H and (13)C tracers to evaluate systemic lipolysis, hepatic glucose production, and mitochondrial pathways (TCA cycle, anaplerosis, and ketogenesis). Individuals with NAFLD had 50% higher rates of lipolysis and 30% higher rates of gluconeogenesis. There was a positive correlation between IHTG content and both mitochondrial oxidative and anaplerotic fluxes. These data indicate that mitochondrial oxidative metabolism is ~2-fold greater in those with NAFLD, providing a potential link between IHTG content, oxidative stress, and liver damage.
Copyright © 2011 Elsevier Inc. All rights reserved.
Figures
Comment in
-
Metabolism: Mitochondrial pathways in NAFLD.Nat Rev Endocrinol. 2012 Jan 10;8(3):129. doi: 10.1038/nrendo.2011.240. Nat Rev Endocrinol. 2012. PMID: 22231854 No abstract available.
References
-
- Barrows BR, Parks EJ. Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. J Clin Endocrinol Metab. 2006;91:1446–1452. - PubMed
-
- Bickerton A, Roberts R, Fielding B, Tornqvist H, Blaak E, Wagenmakers A, Gilbert M, Humphreys S, Karpe F, Frayn K. Adipose tissue fatty acid metabolism in insulin-resistant men. Diabetologia. 2008;51:1466–1474. - PubMed
-
- Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther. 2003;5:1003–1015. - PubMed
-
- Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology. 2004;40:1387–1395. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- TL1 DK081181/DK/NIDDK NIH HHS/United States
- PL1DK081183/DK/NIDDK NIH HHS/United States
- RL9 DK081180/DK/NIDDK NIH HHS/United States
- R01DK078184/DK/NIDDK NIH HHS/United States
- RL9DK081180/DK/NIDDK NIH HHS/United States
- P01 DK058398/DK/NIDDK NIH HHS/United States
- R01DK087977/DK/NIDDK NIH HHS/United States
- UL1 TR000451/TR/NCATS NIH HHS/United States
- UL1RR024982/RR/NCRR NIH HHS/United States
- UL1 RR024982/RR/NCRR NIH HHS/United States
- PL1 DK081183/DK/NIDDK NIH HHS/United States
- 5RL1DK081187/DK/NIDDK NIH HHS/United States
- UL1DE019584/DE/NIDCR NIH HHS/United States
- PL1DK081182/DK/NIDDK NIH HHS/United States
- P01DK058398/DK/NIDDK NIH HHS/United States
- R01 DK078184/DK/NIDDK NIH HHS/United States
- R01 DK087977/DK/NIDDK NIH HHS/United States
- UL1 DE019584/DE/NIDCR NIH HHS/United States
- RL1 DK081187/DK/NIDDK NIH HHS/United States
- K23DK074396/DK/NIDDK NIH HHS/United States
- UL1 RR024923/RR/NCRR NIH HHS/United States
- PL1 DK081182/DK/NIDDK NIH HHS/United States
- P20 RR020691/RR/NCRR NIH HHS/United States
- K23 DK074396/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
